Literature DB >> 12151271

Activation of NF-kappaB and MAP kinase cascades by hypothermic stress in endothelial cells.

Jonathan R Roberts1, Peter A Rowe, Andrew G Demaine.   

Abstract

Signal transduction pathways and transcription factors are likely to be important mediators of stress responses to ischaemia and reperfusion injury following renal transplantation. We have investigated the activation of the transcription factor nuclear factor kappaB (NF-kappaB) and the mitogen activated protein kinases (MAPK), p44/42 (ERK 1/2), p38 and c-Jun N-terminal kinase (JNK) during cold stress at 4 degrees C. Human umbilical vein endothelial cells (HUVECs) were subjected to 72 h of hypothermia in a renal preservation solution. NF-kappaB activation was assessed by electromobility shift assays and MAPK activation by immunoblotting. Cell viability and apoptosis was assessed. Hypothermia activated the NF-kappaB complex, ERK 1/2 and p38 MAPK pathway. There was a 6-fold increase in NF-kappaB in the nucleus within minutes of hypothermia, correlating with p38 (p = 0.01) and ERK 1/2 activation (p = 0.03). A significant relationship was found between ERK 1/2, p38 and NF-kappaB throughout the 72 h time course (p = 0.01). In contrast, hypothermia had no effect on JNK phosphorylation. Inhibition of MAPK with an MEK inhibitor (PD098059) blocked the activation of NF-kappaB but a specific p38 inhibitor (SB203580) had no effect on NF-kappaB. Increased lactate production after 48 h indicated a switch towards anaerobic metabolism during prolonged hypothermia. Endothelial cells had a high viability and no DNA fragmentation throughout the experiment. Activation of stress pathways during organ procurement may be important in the quality of stored grafts.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12151271     DOI: 10.1016/s0011-2240(02)00018-4

Source DB:  PubMed          Journal:  Cryobiology        ISSN: 0011-2240            Impact factor:   2.487


  7 in total

1.  Insulin like growth factor-1 increases fatty liver preservation in IGL-1 solution.

Authors:  Mohamed Amine Zaouali; Susagna Padrissa-Altés; Ismail Ben Mosbah; Hassen Ben Abdennebi; Olivier Boillot; Antoni Rimola; Dalila Saidane-Mosbahi; Joan Roselló-Catafau
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

2.  Piceatannol inhibits MMP-9-dependent invasion of tumor necrosis factor-α-stimulated DU145 cells by suppressing the Akt-mediated nuclear factor-κB pathway.

Authors:  Rajapaksha Gendara Prasad Tharanga Jayasooriya; Yong-Gab Lee; Chang-Hee Kang; Kyoung-Tae Lee; Yung Hyun Choi; Sung-Yong Park; Jae-Kwan Hwang; Gi-Young Kim
Journal:  Oncol Lett       Date:  2012-10-12       Impact factor: 2.967

Review 3.  Winter Hypertension: Potential mechanisms.

Authors:  Auda Fares
Journal:  Int J Health Sci (Qassim)       Date:  2013-06

4.  Relation of season and temperature to endothelium-dependent flow-mediated vasodilation in subjects without clinical evidence of cardiovascular disease (from the Framingham Heart Study).

Authors:  Michael E Widlansky; Joseph A Vita; Michelle J Keyes; Martin G Larson; Naomi M Hamburg; Daniel Levy; Gary F Mitchell; Ewa W Osypiuk; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Am J Cardiol       Date:  2007-06-18       Impact factor: 2.778

5.  Mild Hypothermia Attenuates Intercellular Adhesion Molecule-1 Induction via Activation of Extracellular Signal-Regulated Kinase-1/2 in a Focal Cerebral Ischemia Model.

Authors:  Jung Sook Choi; Jaechan Park; Kyoungho Suk; Cheil Moon; Yong-Ki Park; Hyung Soo Han
Journal:  Stroke Res Treat       Date:  2011-03-16

6.  TIR/BB-loop mimetic AS-1 protects vascular endothelial cells from injury induced by hypoxia/reoxygenation.

Authors:  Zhijia Zhang; Yuxing Hou; Jiantao Li; Chao Tang; Linli Que; Qian Tan; Yuehua Li
Journal:  J Biomed Res       Date:  2019-07-31

7.  Molecular and cellular pathways as a target of therapeutic hypothermia: pharmacological aspect.

Authors:  Hyung Soo Han; Jaechan Park; Jong-Heon Kim; Kyoungho Suk
Journal:  Curr Neuropharmacol       Date:  2012-03       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.